Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
Key Highlights
- ➤Recursion (RXRX) will report third-quarter 2026 results after markets close November 2
- ➤REC-4881 updated FAP data will be presented at the CGA-IGC meeting November 3
- ➤Regulatory update for REC-4881 is expected by year-end
- ➤Webinar will include encouraging REC-1245 monotherapy data and earnings updates
* Webinar will include earnings updates and REC-4881 data as well as KOL and patient panels, presented live from CGA-IGC on Tuesday, November 3, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT * Third quarter 2026 results will be released prior to the webinar, after the close of US markets on Monday, November 2, 2026 Salt Lake City, UT, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2026 financial results on Monday, November 2, 2026, after the close of the financial markets, with live call from the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) Annual Meeting in Denver, Colorado on November 3, 2026, at 8:00 AM ET / 6:00 AM MT / 1:00 PM GMT.
Get started
Create a free account to read the full story.